However, their xenograft models failed to account for the immunosuppressive CRC tumor microenvironment (TME), which contains PD-L1+ myeloid cells and TGF-β (2.1-4.8 ng/ml)(102). The gene discussed is TGFB1; the disease is colorectal carcinoma.